Prot #LOXO-BTK-18001: A Phase 1/2 Study of Oral LOXO-305 in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) or Non-Hodgkin's Lymphoma (NHL)

Project: Research project

Project Details

StatusActive
Effective start/end date12/8/20 → 12/8/23

Funding

  • Covance Inc. (Prot #LOXO-BTK-18001)
  • Loxo Oncology, Inc. (Prot #LOXO-BTK-18001)
View all
View less